Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects

⟵ Back to Search Results

Beigene Study ID

BGB-3111-104

ClinicalTrials.gov ID

NCT03301181

Sex: All

Age: 18 Years to 65 Years (Adult, Older Adult)

No Study Documents

Sex: All

Age: 18 Years to 65 Years (Adult, Older Adult)

No Study Documents